BrainSpec is a Boston-based medical software company that grew out of the Brigham and Women's Hospital iHub community. Its flagship offering is BrainSpec Core, a web-based magnetic resonance spectroscopy platform with cloud processing, a browser viewer, and PACS integration that generates automated reports across scanner vendors. The platform received full FDA clearance in November 2023 for AI-assisted non-invasive measurement of brain chemistry.
The company is led by CEO and co-founder Alexandra Zimmerman alongside co-founder Alexander Lin. BrainSpec is headquartered at 665 Washington Street in Boston and has raised about 1.88 million dollars across five rounds with backing from DCVC, Tuesday Capital, Creative Destruction Lab, Dorm Room Fund, and Right Side Capital. Research collaborations include the University of Minnesota and Washington University School of Medicine.
